These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11856942)

  • 21. Surgical management of fibrous dysplasia in McCune-Albright syndrome.
    Stanton RP; Diamond L
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():446-52. PubMed ID: 17982394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
    Meier ME; Clerkx SN; Winter EM; Pereira AM; van de Ven AC; van de Sande MAJ; Appelman-Dijkstra NM
    J Bone Miner Res; 2021 Sep; 36(9):1729-1738. PubMed ID: 34076303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment for fibrous dysplasia of bone involving proximal femur].
    Li T; Xing B; Duan H; Liu Y; Pei F; Tu C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Mar; 23(3):261-4. PubMed ID: 19366128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome.
    Hauffa BP; Havers W; Stolecke H
    Helv Paediatr Acta; 1987 Jun; 42(5-6):471-80. PubMed ID: 2969881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of deformities of the femur in children with polyostotic fibrous dysplasia].
    Snetkov AI
    Ortop Travmatol Protez; 1984 Apr; (4):25-9. PubMed ID: 6377172
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternative indications for bisphosphonate therapy.
    Landesberg R; Eisig S; Fennoy I; Siris E
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):27-34. PubMed ID: 19371812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
    Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of IL-6 in the treatment of fibrous dysplasia of bone: The randomized double-blind placebo-controlled TOCIDYS trial.
    Chapurlat R; Gensburger D; Trolliet C; Rouanet S; Mehsen-Cetre N; Orcel P
    Bone; 2022 Apr; 157():116343. PubMed ID: 35104665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteosarcoma in a pregnant patient with McCune-Albright syndrome.
    Kanazawa I; Yamauchi M; Yano S; Imanishi Y; Kitazawa R; Nariai Y; Araki A; Kobayashi K; Inaba M; Maruyama R; Yamaguchi T; Sugimoto T
    Bone; 2009 Sep; 45(3):603-8. PubMed ID: 19481621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two stage reconstruction for the Shepherd's crook deformity in a case of polyostotic fibrous dysplasia.
    Nagda TV; Singh H; Kandoi M; Samant A; Patel BR
    J Postgrad Med; 1997; 43(3):83-4. PubMed ID: 10740732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [McCune-Albright syndrome: a difficult and complicated case study].
    Liang LY; Meng Z; Zeng QH; Li WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):311-4. PubMed ID: 16923365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience.
    Valadares LP; de Araújo Ferreira BS; da Cunha BM; Moreira LA; Batista FGA; da Fonseca Hottz C; Magalhães GGR
    Arch Endocrinol Metab; 2022 Apr; 66(2):247-255. PubMed ID: 35420267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation of specific orthopaedic features of polyostotic fibrous dysplasia with functional outcome scores in children.
    Leet AI; Wientroub S; Kushner H; Brillante B; Kelly MH; Robey PG; Collins MT
    J Bone Joint Surg Am; 2006 Apr; 88(4):818-23. PubMed ID: 16595472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.
    Florenzano P; Pan KS; Brown SM; Paul SM; Kushner H; Guthrie LC; de Castro LF; Collins MT; Boyce AM
    J Bone Miner Res; 2019 Apr; 34(4):653-660. PubMed ID: 30645769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical therapy in adults with fibrous dysplasia of bone.
    Chapurlat RD
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P114-9. PubMed ID: 17228999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fibrous dysplasia of bone in a young male].
    Alonso G; Muñoz-Torres M
    Endocrinol Nutr; 2009 Apr; 56(4):195-200. PubMed ID: 19627736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Picture of the month. Polyostotic fibrous dysplasia (McCune-Albright syndrome).
    Gellis SS; Feingold M; Pashayan H; Pruzansky S
    Am J Dis Child; 1973 Nov; 126(5):617-8. PubMed ID: 4745152
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of antiresorptive agents in fibrous dysplasia and McCune Albright syndrome, a systematic review and meta-analysis.
    Bertin H; Moussa MS; Komarova S
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1103-1119. PubMed ID: 37632645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of McCune Albright syndrome.
    Zacharin M
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():412-8. PubMed ID: 17982388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.